These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16581334)

  • 1. An assessment of statin safety by nephrologists.
    Kasiske BL; Wanner C; O'Neill WC;
    Am J Cardiol; 2006 Apr; 97(8A):82C-85C. PubMed ID: 16581334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin safety: lessons from new drug applications for marketed statins.
    Jacobson TA
    Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of statin safety by neurologists.
    Brass LM; Alberts MJ; Sparks L;
    Am J Cardiol; 2006 Apr; 97(8A):86C-88C. PubMed ID: 16581335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of statin safety by muscle experts.
    Thompson PD; Clarkson PM; Rosenson RS;
    Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of statin safety by hepatologists.
    Cohen DE; Anania FA; Chalasani N;
    Am J Cardiol; 2006 Apr; 97(8A):77C-81C. PubMed ID: 16581333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
    McKenney JM; Davidson MH; Jacobson TA; Guyton JR;
    Am J Cardiol; 2006 Apr; 97(8A):89C-94C. PubMed ID: 16581336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins, cardiovascular disease, and drug safety.
    Gotto AM
    Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of statin safety.
    McKenney JM
    Am J Manag Care; 2006 Oct; 12(11 Suppl):S310-7. PubMed ID: 17042673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of statins on renal function.
    Agarwal R
    Am J Cardiol; 2006 Mar; 97(5):748-55. PubMed ID: 16490450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin: renal disorders and rhabdomyolysis.
    Prescrire Int; 2007 Apr; 16(88):68-9. PubMed ID: 17458050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin safety: an overview and assessment of the data--2005.
    Bays H
    Am J Cardiol; 2006 Apr; 97(8A):6C-26C. PubMed ID: 16581330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin induced proteinuria: renal injury or renoprotection?
    Agarwal R
    J Am Soc Nephrol; 2004 Sep; 15(9):2502-3. PubMed ID: 15340001
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of statin-associated proteinuria.
    Tiwari A
    Drug Discov Today; 2006 May; 11(9-10):458-64. PubMed ID: 16635810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do HMG-CoA reductase inhibitors improve kidney function? The saga continues.
    Campese VM; Ku E; Bigazzi R; Bianchi S
    J Nephrol; 2011; 24(5):550-3. PubMed ID: 21887675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment by the Statin Muscle Safety Task Force: 2014 update.
    Rosenson RS; Baker SK; Jacobson TA; Kopecky SL; Parker BA; The National Lipid Association's Muscle Safety Expert Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S58-71. PubMed ID: 24793443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of statins.
    Brown WV
    Curr Opin Lipidol; 2008 Dec; 19(6):558-62. PubMed ID: 18957877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks associated with statin therapy: a systematic overview of randomized clinical trials.
    Kashani A; Phillips CO; Foody JM; Wang Y; Mangalmurti S; Ko DT; Krumholz HM
    Circulation; 2006 Dec; 114(25):2788-97. PubMed ID: 17159064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.